Monday, August 03, 2015 4:27:22 PM
4:20 PM ET 8/3/15 | Briefing.com
Reports Q2 (Jun) earnings of $0.10 per share, $0.06 better than the Capital IQ Consensus Estimate of $0.04; revenues rose 78.3% year/year to $63.31 mln vs the $61.91 mln consensus.
Co issues downside guidance for Q3, sees Q3 revs of $61-63 mln vs. $67.38 mln Capital IQ Consensus Estimate. Co issues downside guidance for FY15, sees FY15 revs of $244-248 mln vs. $261.52 mln Capital IQ Consensus Estimate.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM